ArticleCureus2026
Laboratory Aspects and Diagnostic Challenges in a Case of Hypereosinophilic Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypereosinophilia is defined by a persistent increase in eosinophil levels and can lead to multi-organ damage with highly variable symptoms. The most common manifestations involve the skin, lungs, and gastrointestinal tract, while cardiac and neurological complications can be particularly severe and sometimes fatal. Within this context, we describe the case of a 35-year-old woman with hypereosinophilic syndrome (HES), whose symptoms began during pregnancy. Three months after giving birth, she contracted SARS-CoV-2, which resolved without complications. However, shortly thereafter, laboratory tests revealed marked leukocytosis accompanied by a rapid clinical deterioration. At admission, the patient displayed severe hypereosinophilia associated with systemic inflammation, liver injury, myocardial necrosis, and multi-organ involvement affecting the kidneys, brain, heart, and lungs. As her neurological condition worsened, she required admission to the intensive care unit, where she unfortunately died four days later. The aim of this case report is to raise awareness among clinicians and laboratory professionals about the crucial role of the laboratory finding in assessing disease severity and guiding the diagnostic challenges of idiopathic syndrome (I-HES). The exclusion of secondary causes confirmed the idiopathic nature of the condition. Finally, the case highlights the importance of early recognition of unexplained eosinophilia and systemic symptoms, as timely intervention may be life-saving in rapidly progressive presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.